Introduction
BPAG1e, missing in BPAG1t, is predicted to associate with keratin IFs. If BPAG1n contains this putative IF The 230 kDa epidermal form of bullous pemphigoid antidomain of BPAG1e, it might have the extraordinary cagen 1 (BPAG1e), first identified with antisera from papacity to bind simultaneously to both actin microfilatients with the autoimmune disorder, bullous pemphiments (MFs) and IFs. On the other hand, if BPAG1n goid (BP; Stanley, 1993) , belongs to a small group of is missing this domain, it might differ completely from large coiled-coil proteins that includes desmoplakin and BPAG1e in its cytoskeletal associations. In this report, plectin . Both desmoplakin and plecwe determine the complete structure of BPAG1n protein tin can associate with intermediate filaments (IFs) and show that it has functional actin-and neurofilament (Foisner et al., 1991; Stappenbeck and Green, 1992;  (NF)-binding sites at opposite ends of its coiled-coil Kouklis et al., 1994) . While plectin decorates IF networks rod. Accumulating along the length of sensory axons, and is expressed ubiquitously, desmoplakin connects BPAG1n represents a novel class of cytoskeletal protein IFs to desmosomes in muscle and stratified epithelia.
that serves a key in vivo role of linking actin and IF Similar studies have not yet been conducted with arrays. Our findings provide insights into the possible BPAG1e, although this protein localizes to the intracellurelation of recessive BPAG1 mutations to severe human lar portion of the hemidesmosomal plaque, in a region neurodegenerative disorders. where keratin filaments associate with the plaque (Stanley, 1993) . Recent knockout studies revealed that basal epidermal cells lacking BPAG1e have hemidesmosomes Results with seemingly normal structure, but with severed connections to the keratin IF cytoskeleton (Guo et al., 1995) .
The Brain Form of BPAG1 Contains the Complete
Coding Sequence of BPAG1e, minus Exon 1 Surprisingly, ablation of the BPAG1 gene in mice (Guo et al., 1995) produced gross, rapid sensory neuron deTo identify the form of BPAG1 expressed in brain, we screened a human fetal brain cDNA library with a cDNA generation identical to dystonia musculorum (dt/dt), a well-known autosomal recessive mouse mutant (Duto exons 2-5 of the epidermal form of BPAG1. Five different cDNAs were identified. Rapid amplification of chen, 1976). While allelic with our BPAG1 null mice, only one of two previously identified dt/dt mouse strains cDNA ends (RACE) completed the encoded amino-terminal segment. Sequencing revealed the existence of lacked BPAG1e, leading us to predict the existence of (A) PCR analysis of mouse and human skin and brain BPAG1 mRNAs. Total RNAs were isolated from skin (S) and brain (B) tissues of human or 14-day-old wild-type (wt) and BPAG1 null (Ϫ/Ϫ) mice. Oligonucleotide primers were used to PCR amplify mouse and human BPAG1 sequences, and DNA fragments were resolved by agarose gel electrophoresis (2% left gel; 1% right gel) and visualized by ethidium bromide staining. Shown are mouse data. Fragments encompassed are as follows: lanes 1 and 2, exons 1 and 2 of BPAG1e; lanes 3 and 4, exon 2 of BPAG1e; lanes 5 and 6, ␤-actin cDNA (control); lanes 7 and 8, exons 15-21, which comprise the coiled-coil rod of BPAG1e; and lanes 9-11, the nonhelical tail of BPAG1e. Migration of DNA standards are indicated at left and right. (B) Northern blot analysis of mouse skin and brain BPAG1 mRNAs. Poly(A) ϩ RNAs (2 g) were resolved by electrophoresis through formaldehyde-agarose gels (0.6%). RNAs were transferred by blotting to nitrocellulose, and blots were hybridized with 32 P-labeled cDNA probes against (top) a 680 bp mouse BPAG1n cDNA corresponding to the 5Ј coding segment unique to BPAG1n, (middle) a 1.2 kb mouse BPAG1e cDNA spanning parts of exons 21 and 22 (3Ј coding segment), or (bottom) a 1 kb mouse glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA (control). Migration of RNA standards is indicated at left. (C) Immunoblot analysis of skin (S), brain (B), and spinal cord (SC) proteins isolated from (Ϫ/Ϫ) and wild-type mice. Protein extracts in 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 0.1% SDS, 5 mM EDTA were resolved by electrophoresis through 6% SDS-polyacrylamide gels and then transferred to nitrocellulose by electroblotting. Blots were stained with Ponceau red (data not shown) to examine relative loadings and then subjected to immunoblot analysis with (left) m5E monoclonal antibody against a BPAG1 tail epitope (1:500 dilution) and (right) anti-BPAG1n (1:1000 dilution). Horseradish peroxidase secondary antibodies and chemiluminescence were used to develop the signal. Migration of muscle myosin (200 kDa) control is shown. Note single BPAG1n band, despite the existence of two isoforms based on cDNA analysis. (D) Diagram of four human BPAG1 isoforms. Shown are protein structures of two BPAG1n isoforms, determined from amino acid 1 through exon 2 (II) of BPAG1e by Brown et al. (1995a Brown et al. ( , 1995b and assessed in their entirety here. Numbers at top represent amino acids of the BPAG1n1 sequence. Shown also is the complete protein structure of human BPAG1e, with a unique exon 1 (I) determined by Tamai et al. (1993) , and the hypothesized structure of the 280 kDa human pancreatic BPAG1t, partially cloned as a putative tailless BPAG1 (Hopkinson and Jones, 1994). two transcripts that differ in their 5Ј sequence, encoding sets encompassing BPAG1e, including the ‫526ف‬ amino acid residue coiled-coil "rod" (exons [16] [17] [18] [19] [20] and the 768 a divergent initial 31 (for BPAG1n1) and 215 (for BPAG1n2) amino acids, followed by 352 shared residues residue "tail" (exons 21 and 22) (Tamai et al., 1993) . In all cases, PCR bands were generated from skin and prior to amino acid residue 55 of BPAG1e. These two brain forms matched with recently published 5Ј segbrain RNAs; these bands were not present in RNAs from BPAG1 (Ϫ/Ϫ) knockout mice. Sequence analyses of the ments of human brain BPAG1n cDNA (Brown et al., 1995b) . To identify the more carboxy-terminal structures isolated cDNA clones showed that the encoded 1103 amino acid "head" (exons 2-15) was present in both of the two brain BPAG1s, reverse transcriptase-polymerase chain reaction (RT-PCR) of isolated mouse brain BPAG1n1 and BPAG1n2. Sequence analyses of the PCR fragments confirmed that the remaining exons of RNA was used to amplify the coding segments of BPAG1n1 and BPAG1n2 mRNAs ( Figure 1A ). are present in brain RNAs. Northern blot analysis demonstrated the existence of cleotide primers spanning exons 1 and 2 of BPAG1e amplified a band only in skin and not in brain. In contrast, a 12 kb brain BPAG1n RNA(s) hybridizing to radiolabeled probes to the 5Ј and 3Ј sequences common to both primer pairs within exon 2 generated a band in both skin and brain. Similar data were obtained with human RNAs
BPAG1n isoforms ( Figure 1B ). This RNA was not detected in whole skin preparations or in brain tissue from (data not shown). Collectively, these results verified the existence of human and mouse RNAs encoding the BPAG1 knockout mice (Ϫ/Ϫ). Thus, the 12 kb BPAG1n mRNA is not appreciably expressed in skin, in contrast cloned BPAG1n cDNAs, and revealed that the BPAG1e form is not expressed in brain.
with prior predictions based on detection of a BPAG1-related RNA in a cultured epithelial line (Brown et al., To determine the remainder of the BPAG1n1 and BPAG1n2 sequences, we used oligonucleotide primer 1995a).
The ‫082ف‬ kDa BPAG1n Protein Is Present in Brain and Spinal Cord
To verify the existence of BPAG1n protein, immunoblots of extracts from skin, brain, and spinal cord were probed with a monoclonal antibody (E5a) made from a BP patient autoantisera and recognizing an epitope in the BPAG1e tail segment (Sugi et al., 1989) . In addition to binding to the 230 kDa BPAG1e band in skin, this antibody detected a 280 kDa band in brain and spinal cord ( Figure 1C ). That this band corresponds to BPAG1n was confirmed by probing a second blot with a rabbit antiserum prepared against the putative ABD of BPAG1n fused to glutathione S-transferase (GST). We conclude that a single protein contains the carboxy-terminal sequence common to skin and brain BPAG1 isoforms as well as the amino-terminal sequence encoded by the brain cDNAs. The size of the BPAG1n band corresponded to that predicted for BPAG1n1, although the antibody should have detected both isoforms with equal affinity. A minor band of ‫052ف‬ kDa was also detected (see lane 1 of Figure 1C ); its identity remains unknown. Figure 1D summarizes the structure of BPAG1n1 and BPAG1n2 relative to other BPAG1 forms. Since dystonia musculorum does not appear to be a bona fide model of human dystonia, and since both brain and skin BPAG1s are antigenic determinants of BP autoantisera, we have kept the nomenclature first set for the epidermal form, and henceforth we refer to the 280 kDa band detected in Figure 1C as BPAG1n.
BPAG1n Is Expressed Primarily in Sensory Neurons
To examine the role of BPAG1n in the central and peripheral nervous system, we first used in situ hybridization to determine where BPAG1n mRNAs are expressed. As shown in Figure 2A and viewed at higher magnification in Figure 2B , the perikarya of the dorsal root ganglia (DRG) neurons of neonatal mice hybridized with didegoxygenin-labeled, BPAG1n-specific cRNA. When compared with a trkC probe, which labeled the 1a afferent subset of primary sensory neurons ( Figure 2C ), it was clear that BPAG1n mRNAs were expressed more widely within the sensory neuron population ( Figure 2B ). The smaller satellite cells within the DRG did not appear to In situ hybridizations were performed on frozen transverse sections Moreover, in contrast with the BPAG1n cRNA labeling from postnatal day 1 mice according to Yang et al. (1996) . Hybridizain the DRG, neither the spinal cord, sensory roots, nor tions using didegoxygenin (DIG) cRNAs were performed for 16 hr peripheral nerves gave labeling above background. Colat 72ЊC, followed by stringent washes for 3 hr at 72ЊC in 0.2ϫ SCC. lectively, our data demonstrated, first, the existence of Frozen tissue sections (20 m) of brain, spinal cord, and skin were taken from wild-type (A, B, and D-I) and BPAG1 null (C) mice at 12 days after birth. Sections were treated with methanol (Ϫ20ЊC) for 10 min, washed three times with phosphate-buffered saline (PBS), preblocked with 1% BSA, 0.1% Triton X-100, and 1% gelatin in PBS, and then exposed to anti-BPAG1n (1:100 dilution) at room temperature overnight. After washing three times with PBS for 10 min each, sections were incubated with secondary antibody (1:50 dilution) conjugated with immunogold for 30 min, and then washed and mounted. Sections were examined using a Zeiss Axiophot immunofluorescence microscope. All signals shown were specific for BPAG1n and were not seen in BPAG1 (Ϫ/Ϫ) sections. ( Figure 3C ), axons within the dorsal column of wild-type 2, present in both BPAG1e and BPAG1n. Axons in the spinocerebellar tract also stained positive for BPAG1n mice were strongly positive ( Figure 3D ). Sagittal sections of dorsal column revealed staining along its length (Fig- (data not shown). These secondary nerve fibers serve as important sensory relays to the brain, where they ures 3E and 3F). Closer inspection of this region showed that the staining was specific for sensory nerve fibers deliver signals that originate from primary sensory fibers coming from muscle. Thus, expression of BPAG1n was ( Figure 3F ).
In contrast with the immunoreaction in the dorsal colnot restricted to primary sensory neurons, but extended to some secondary sensory neurons. umn, the ventral portion of the spinal cord displayed little or no detectable staining with anti-BPAG1n (Figure Our findings are consistent with the pathology of the BPAG1 knockout and dt/dt mice, but they differ mark-3D), a finding expected from the absence of BPAG1n RNAs in similar sections (Figure 2A ). These data argue edly from the predictions of BPAG1n expression inferred from following expression of a hsp70-lacZ transgene that the majority of motor dysfunction in the BPAG1 knockout mice is secondary. Consistent with this notion integrated into the BPAG1 locus in a dt/dt mouse mutant (Kothary et al., 1988) . is that the sciatic nerve, which contains a mixture of motor and sensory axons, displayed some axons that stained with anti-BPAG1n and others that did not (Fig- The BPAG1 Tail Associates with IF Networks The carboxy-terminal tail of desmoplakin associates ure 3G).
Anti-BPAG1n staining was also detected in muscle with epidermal keratin networks in vivo (Kouklis et al., 1994) . Given 40% amino acid sequence identity between spindles, the stretch receptors in skeletal muscle that are innervated by sensory nerve terminals from the DRG an ‫003ف‬ residue portion of the tails of desmoplakin and BPAG1 , and given the finding that as well as motor neurons ( Figure 3H ). BPAG1n antibody staining was also found in the sensory nerve termini ablation of BPAG1e severs the connection between keratin IFs and hemidesmosomes (Guo et al., 1995) , we within skin ( Figure 3I ). The epidermal labeling was likely due to the ability of the antibody to detect BPAG1 exon tested whether the BPAG1 tail might have the capacity to associate with IF networks. The entire 768 residue posttransfection, implying that the BPAG1 tail is stabilized by binding to an IF array. tail of human BPAG1n/e, tagged at its amino terminus with a small epitope (FLAG), was expressed transiently
To verify that the association between BPAG1 tail and NFs was specific, transfections were repeated in in SCC-13 keratinocytes. The BPAG1 tail decorated the epidermal IF network (Figures 4A-4C) , which in the mamonkey kidney epithelial (COS) cells that harbor the simian virus 40 (SV40) T antigen, resulting in amplificajority of transfected cells was unaffected by the transgene product.
tion of the transfected plasmids. Following transfection, cell extracts were prepared and first subjected to immuWhen expressed in the SW13 cell line lacking cytoplasmic IFs, the BPAG1 tail accumulated diffusely in the noblot analyses to verify that the proteins were stably expressed and of the expected size. As shown in Figure  cytoplasm , devoid of a filamentous appearance ( Figure  4D ). An immunofluorescence signal could only be seen 5A, the ‫08ف‬ kDa BPAG1 tail protein accumulated, as did NF-L ‫07ف(‬ kDa), NF-H ‫002ف(‬ kDa), and full-length at early timepoints after transfection (e.g., 24 hr), suggesting that the protein is unstable in this cell line. In BPAG1n (280 kDa).
To examine the specificity of the association between contrast, when an extensive array of NFs was produced in vivo by cotransfection with a 1:1 ratio of NF-L (light the BPAG1 tail segment and NFs, we transfected COS cells with the BPAG1 tail or NF-H constructs (or both) chain) and NF-H (heavy chain) expression vectors (Lee et al., 1993) , the BPAG1 tail decorated the cytoskeletal and incubated the cells in the presence of medium containing [
35 S]methionine. After 28 hr, extracts were subarray of NFs (Figures 4E-4G ). In this case, the anti-FLAG immunofluorescence signal was strong even at 40 hr jected to immunoprecipitation with antibodies against the FLAG-tagged BPAG1 tail. As judged by SDSpolyacrylamide gel electrophoresis and autoradiography, a band of the expected size of NF-H selectively associated with the 80 kDa BPAG1 tail and was coimmunoprecipitated with the antibody ( Figure 5A ). Immunoblot analysis of unlabeled COS cell extracts confirmed that this ‫002ف‬ kDa band was indeed NF-H. The stoichiometry of the association was ‫,1:1ف‬ when size and methionine content were considered and when the radioactivity in the bands was quantitated. When expressed by itself, NF-H remained in the soluble fraction of detergent-containing cell extracts immunoprecipitated with anti-BPAG1n. However, following cotransfection, BPAG1 antibody immunoprecipitated NF-H nearly as efficiently as the NF-H antibody, confirming the association between the two proteins.
The Amino-Terminal Domain of BPAG1n Binds Actin Filaments In Vivo and In Vitro
The location of anti-BPAG1n labeling within the axon, coupled with the presence of a putative ABD in the amino-terminal portion of BPAG1n, suggested that BPAG1n might be tethered to the cytoskeleton of actin MFs known to be present in the axon (Hirokawa, 1982; Fath and Lasek, 1988) . To assess whether this domain has the capacity to associate with the actin cytoskeleton, we used DNA transfection to express the aminoterminal portion of BPAG1n1 in SW13 cells. As shown in Figures 4H-4J , antibodies against BPAG1n and ␤-actin colocalized along the actin stress fibers and at the cortical actin cytoskeleton underlying the plasma membrane of these cells. Greater than 80% of the transfected cells displayed this phenotype. This portion of BPAG1n did not localize with NFs in cotransfected cells ( Figure 4K ). To explore further the specificity of the amino-terminal domain of BPAG1n for actin filaments, polymerized actin was combined with GST-BPAG1n fusion protein (100 . We lysed cells 36 hr after transfection and resolved total proteins by electrophoresis through 10% or 6% (B) Actin binding assays. Binding assays were conducted as de-SDS-polyacrylamide gels. Following transfer to nitrocellulose, blots scribed by Lo et al. (1994) to test the following: the ABD II of chicken were first stained with Ponceau red to verify equal loading of protein tensin fused to GST (tensin; purified from p23-expressing cells; Lo (data not shown) and then subjected to immunoblot analysis with et al., 1994); the ABD sequence of human brain BPAG1n fused to anti-FLAG (lane 1), anti-NF-L (lane 2), anti-NF-H (lane 3), or anti-GST (BPAG/ABD); bovine serum albumin control (BSA); and GST BPAG1n (lane 4). After washing, the blots were developed using protein control (data not shown). In brief, proteins (80 g/ml) in P enhanced chemiluminescence. Note the presence of a single band buffer (10 mM imidazone [pH 7.0], 75 mM KCl, 0.2 mM EGTA, 0.01% of the expected size for each of the cell extracts. COS cells were also NP-40) were subjected to precentrifugation in a Beckman Airfuge radiolabeled with 10 Ci/ml [ 35 S]methionine (1 Ci/mmol; Amersham) to remove any aggregates and then combined with purified rabbit following transfection with a 1:1 molar ratio of pFG-BPAG1tail and skeletal muscle F-actin (300 g/ml in 0.2 mM ATP). After incubation MSV-NFH (lane 5), MSV-NFH (lane 6), or pFG-BPAG1tail (lane 7).
(1 hr at room temperature), samples were subjected to centrifugation After 28 hr, cells were processed for immunoprecipitation with anti-(100,000 ϫ g for 40 min) to pellet the F-actin and its associated FLAG antibody in 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, 0.1% proteins. Fractions were then separated by electrophoresis through SDS, 5 mM EDTA. Following electrophoresis, the gel was subjected 8.5% SDS-polyacrylamide gels, which were then stained with Cooto autoradiography and exposed to X-ray film for 17 hr. Note that massie blue to visualize protein. The amounts of protein in the superin the presence of BPAG1 tail, NF-H is selectively immunoprecipinatant (S) or actin-containing pellet (P) were determined by densitotated by anti-FLAG; vimentin (57 kDa), which also associates with metric scanning. Each assay was performed with (ϩ) and without the BPAG1 tail, is outside the size range necessary to visualize NF-H (Ϫ) polymerized actin filaments. and BPAG1 tail. Finally, unlabeled COS cells were transfected, and (C) Estimation of the Kd of actin binding. Actin filament binding immunoprecipitations were conducted. Following electrophoresis, assays were carried out as in (B), except that BPAG1n fusion protein proteins were transferred to nitrocellulose, and the blot was probed was used at 100 nM, 200 nM, 300 nM, and 400 nm. Scatchard with anti-NF-H and processed. Transfections and antibodies used analysis was conducted on two data sets, which were averaged for immunoprecipitations were as follows: lane 8, pFG-BPAG1tail, (values differed by less than 10%). Plot shown gives, on the vertical anti-FLAG; lane 9, MSV-NFH, anti-FLAG; lane 10, MSV-NFH plus axis, BPAG1n bound/free BPAG1n M Ϫ1 , and on the horizontal axis, pFG-BPAG1tail, anti-FLAG; lane 11, MSV-NFH, anti-NF-H.
bound BPAG1n/F-actin. taining a bona fide ABD (Lo et al., 1994) . In the absence labeled with antibodies against NF-H ( Figure 6A ). However, in contrast with what we had observed in cotransof polymerized actin, neither ABD pelleted by centrifugafections with the BPAG1 tail domain, this NF network tion at 100,000 ϫ g ( Figure 5B ). In contrast, addition of coaligned with the actin stress fiber network ( Figure 6C ). polymerized actin resulted in a major portion of the ABD This association between the two cytoskeletal networks now pelleting with actin. That these associations were involved BPAG1n ( Figure 6B ). The actin network, anspecific to ABD-containing proteins was underscored chored to the cortical cytoskeleton and to focal conby the failure of serum albumin or GST alone to shift to tacts, appeared less affected than the NFs, which are the pelletable fraction in this assay (see also Lo et al., free in the cytoplasm of SW13 cells transfected with 1994, and references therein). Note that some actin did NF-L and NF-H alone. Approximately 20% of triple not pellet, but the relative percentage of actin that retransfected cells showed complete colocalization of all mained in solution was constant irrespective of whether three antibodies, 50% showed partial colocalization, an ABD was added to the polymerized preparation. This and ‫%03ف‬ of the cells overexpressed one or more of presumably was reflective of unpolymerized actin.
the transgene proteins and therefore could not be cateTo estimate the binding constant of this association, gorized. Only a small percentage (<5%) of cells expresswe repeated these experiments, this time using a range ing BPAG1n displayed distinct actin and NF networks. of BPAG1n concentrations from 100 nm to 400 nm. As
The association of the actin and NF networks in SW13 expected, as the concentration of BPAG1n increased, cells expressing BPAG1n did not appreciably affect the the association of BPAG1n with polymerized actin bemicrotubule cytoskeleton. As shown in Figures 6D-6F , came saturating, and the level of BPAG1n in the soluble the cytoskeleton formed among actin, BPAG1n, and NFs fraction increased. A Scatchard plot of the data is shown did not colocalize with the microtubule network. Thus, in Figure 5C . The Kd of BPAG1n binding to actin was if there are associations between BPAG1n and microtu-2.1 ϫ 10 Ϫ7 M, within the range of that observed for bules, these associations were not detected under the ␤-spectrin and other proteins with ABDs (Lo et al., 1994) .
conditions used here.
Full-Length BPAG1n Has the Remarkable Capacity
Abnormalities in the Neurofilament Architecture to Coalign Actin and NF Networks in BPAG1 Knockout Mice In view of the ABD at one end of the coiled-coil rod
In view of the reorganization of the NF network in SW13 segment of BPAG1n and an NF-binding domain at the cells cotransfected with BPAG1n, we reexamined the other end, we examined the ability of these associations pathology of the BPAG1 knockout animals to assess to take place simultaneously. In this case, we conwhether the NF network within sensory axons might be structed a full-length cDNA for the 280 kDa BPAG1n altered when BPAG1n is missing. First, we used the and expressed it by DNA transfection. By immunoblot mouse monoclonal antibody SMI 31, which detects analysis, a band of the expected size was produced NF-H when it is multiphosphorylated within its lysine-( Figure 5A, lane 4) . When NF-L, NF-H, and BPAG1n were serine-proline repeats in the tail (Sternberger and Sternberger, 1983 ). This antibody reacts broadly with axons, cotransfected into SW13 cells, NFs were formed that BPAG1 (Ϫ/Ϫ) mice and control littermates at 12 days of age were perfused with a solution of 2% glutaraldehyde and 4% paraformaldehyde, and tissues were embedded in Epon. Tissues were processed as previously described (Coulombe et al., 1991) but nerve cell bodies are unreactive. In contrast, many average of 56% Ϯ 17% difference in NF density per unit area of axon cytoplasm. The initial reduction in NF cell bodies of the BPAG1 (Ϫ/Ϫ) DRG were labeled (data not shown). Similar aberrations have been described in density seemed most prominent in areas close to the axonal membrane. Accompanied by a reduction and certain degenerative disorders of motor neurons where NFs accumulate in perikarya disorganization of NFs in axons was an accumulation of NFs in cell bodies ( Figure 7E ). al., 1993).
Electron microscopy was used to examine the NF network in 12d BPAG1 (Ϫ/Ϫ) sensory axons in greater Discussion detail. Approximately 30% of the axons in the dorsal column of the spinal cord were degenerated ( Figure 7A) , A Novel Kind of Cytoskeletal Connector: Linking Actin and IFs a number which would rise to >90% by 4-5 weeks of age (Guo et al., 1995) . In contrast, the ventral root, housOur biochemical and molecular analyses indicate that both neuronal isoforms of BPAG1 have the capacity to ing motor axons emerging from the (Ϫ/Ϫ) spinal cord, was largely unaffected ( Figure 7C) . bind simultaneously to the actin and IF cytoskeletons. An ABD, not present in BPAG1e, resides at the amino Inspection along the length of the DRG axons revealed regional swellings filled with lysosomal vesicles and disend of the coiled-coil rod. Its binding to polymerized actin is with an affinity comparable with, if not stronger organized arrays of neurofilaments ( Figure 7D ). Both myelinated and nonmyelinated fibers seemed to be afthan, that of the well-established actin binding activity of tensin (Lo et al., 1994) . At the carboxy end of the rod fected. Axonal degeneration was also accompanied by a reduction of NFs. In the dorsal column, there was an is an IF-binding domain, present in both BPAG1e and BPAG1n. In keratinocytes, this domain associates with Tsukita et al., 1986) . Additionally, Fath and Lasek (1988) have found a lattice of shorter, but abundant actin MFs the keratin cytoskeleton, and in sensory neurons it binds to NFs.
in the axoplasm of squid DRGs, suggesting that actin MFs play a role in the dynamic architecture of the central Most remarkable is the ability of full-length BPAG1n to realign NFs in relation to the actin cytoskeleton in axon. It has been widely speculated that the axonal network of actin interacts with microtubules to play a transfected SW13 cells. Thus, the binding of BPAG1n to one cytoskeletal network does not preclude its ability role in vesicle transport (Griffith and Pollard, 1978; Nemhauser and Goldberg, 1985) . It may be that in the to associate with the other. This differs from brain ␤-spectrin, which in one report appeared to bind either BPAG1n null mice, NFs become disorganized, resulting in perturbations in these connections. NFs or actin MFs through the ABD (Frappier et al., 1992) . Our demonstration that the ABD of BPAG1n associates It seems likely that severing the BPAG1n connection between NFs and MFs affects axonal transport. It has only with actin filaments and not NFs further underscores this distinction.
already been established that aberrations in motor neuron NFs, similar to the ones we describe for BPAG1 More relevant to BPAG1n is that antibodies against plectin partially localize not only to IFs, but also to actin (Ϫ/Ϫ) sensory neuron NFs, negatively affect axonal transport (Collard et al., 1995) . In addition, we cannot stress fibers and focal contacts in cultured cells (Foisner et al., 1991; Seifert et al., 1992) . That plectin may crossrule out the possibility that the actin cytoskeleton may be perturbed in BPAG1 (Ϫ/Ϫ) mice. In this regard, it link actin and IF networks has recently been proposed by Foisner et al. (1995) , who showed by immunoelectron is interesting that biochemical disruption of MFs also blocks axonal transport (Nemhauser and Goldberg, microscopy that antibodies against plectin label crossbridge-like structures that connect IFs with actin MFs 1985, and references therein). It is interesting that the axon termini of certain sensory in cytoskeletal extracts from glioma cells expressing endogenous plectin. While this observation is intriguing, neurons contain BPAG1n. That BPAG1n function is important in these regions is underscored by the degenerathe partial colocalization by immunofluorescence, coupled with the potential for artifacts in in vitro cytoskeletal tion of muscle spindles and nerve endings in the skin of BPAG1 (Ϫ/Ϫ) mice (Guo et al., 1995; Sotelo and Guenet, preparations , has made it difficult to assess whether these cross-bridges exist in vivo, whether they perform 1988). Although terminal boutons of parasympathetic and motor axons have few if any NFs (Lasek and Hoffa functional role, and whether the interaction, if real, involves direct bridging by a single molecule. The role of man, 1976), the sensory axon termini at muscle spindles and in skin may be more similar to the extensively this association has been further complicated by studies suggesting that plectin also associates with microtubranched preterminal regions of parasympathetic axons, which are rich in NFs (Paggi and Lasek, 1987) . bules and with ␤-spectrin (Foisner et al., 1991 (Foisner et al., , 1995 .
While the role of plectin in the cytoskeleton awaits Finally, it is intriguing that muscle spindles depend upon their sensory nerves (and not their motor nerves) for the generation of plectin null cells or animals, plectin may perform a similar function to BPAG1n. We note here development and survival during the first 2 weeks after birth (Zelena and Soukup, 1974) , providing a partial exthat this seems even more likely given that plectin shares homology between amino acid residues 175-425 and planation as to why motor dysfunction occurs in the BPAG1 knockout mice. To what extent BPAG1n may the ABDs of BPAG1n and ␤-spectrin. In contrast to plectin, however, BPAG1n does not seem to associate apperform multifaceted functions in the axons and axon termini will need to be explored in more detail in the preciably with microtubules, at least in the culture studies described in this report. Whether BPAG1n associates future. with other proteins, as plectin seems to do, remains to be elucidated.
Why Would Disrupting the Linkage between Actin
The BPAG1 knockout provides direct genetic eviand NF Selectively Kill Sensory Neurons? dence that BPAG1n performs an essential function in If BPAG1n provides a linkage between MFs and NFs, sensory neurons. Our immunohistochemistry and in situ when are these linkages formed and are they more imhybridizations reveal that BPAG1n is predominantly in portant to sensory neurons than to other neurons? The axons and axon termini and not in the cell bodies of BPAG1 (Ϫ/Ϫ) phenotype indicates that the attachment sensory neurons. Further, the perturbation seen by elecis most needed following stable synapse formation in tron microscopy in the axonal cytoskeleton of BPAG1 postnatal axons and preterminal axon branches. (Ϫ/Ϫ) mice strongly implies that BPAG1n performs an Whether the attachment is inhibitory to migrating neuactin-NF linkage in vivo and provides a graphic illustrarons, either developmentally or in response to injury, tion of the vital features of this novel type of cytoskeletal will be of interest to address in the future, as is the issue connector protein.
of how BPAG1n is prevented from associating with the actin cytoskeleton in DRG perikarya where it is first synthesized.
What Is the Function of a Molecule That Can Link Actin to NFs?
It is perplexing that BPAG1n is not comparably expressed in motor neurons. Sensory neurons can vary BPAG1n now provides a molecular mechanism by which the NF network can be tethered not only to the cortical dramatically in size, myelination, and axonal transport rates, and hence any of these properties alone is unlikely cytoskeleton, but also to the axoplasmic actin cytoskeleton. (Durham, 1992) , suggesting that the IF cytoskeleton of motor neurons might be selectively more fragile than Albers, K., and Fuchs, E. (1987) . The expression of mutant epidermal that of sensory neurons. While future studies will be keratin cDNAs transfected in simple epithelial and squamous cell necessary to assess whether this is the case, this could carcinoma lines. J. Cell Biol. 105, [791] [792] [793] [794] [795] [796] [797] [798] [799] [800] [801] [802] [803] [804] [805] [806] also explain why mutations in NF genes give preferential Brown, A., Bernier, G., Mathieu, M., Rossant, J., and Kothary, R. loss of motor, but not sensory, neurons in transgenic (1995a) . The mouse dystonia musculorum gene is a neural isoform mice (Cote et al., 1993; Xu et al., 1993) . These results of bullous pemphigoid antigen 1. Nature Genet. 10, 301-306. have important implications for our understanding not Brown, A., Dalpe, G., Mathieu, M., and Kothary, R. (1995b) . Cloning only of the role of actin-IF associations in vivo, but also and characterization of the neural isoforms of human dystonin. Genomics 29, [777] [778] [779] [780] of the source of neuronal degeneration in BPAG1 null mice and in related human neurodegenerative disorders.
